We're Hiring Menu

Our Leadership

Close

Marc Berger

Interim Chief Executive Officer

Marc Berger is Interim Chief Executive Officer at Verana Health. He was previously Senior Vice President at Verana Health and a member of the core leadership team responsible for setting Verana’s corporate strategy. He served as the company’s General Counsel and Privacy Officer and was responsible for the company’s legal functions, including corporate, privacy, commercial contracting, health law, and intellectual property activities. As Senior Vice President, he also oversaw Verana’s Security & Compliance and People & Culture teams.

Prior to joining Verana Health, Marc was General Counsel at Flatiron Health, where he was a member of the four-person team that negotiated the $2.1B acquisition by Roche. Marc has also served as Vice President and Assistant General Counsel at Medidata Solutions, where he had global responsibility for negotiating agreements with life science companies and partners for Medidata’s clinical trial technology and service offerings.

Marc received his JD and MBA from the University of Miami School of Law, and his BS in Management and International Business from Penn State University.

Marc Berger on LinkedIn
Marc Berger

Why Verana?

I love working at mission-driven companies. Verana’s deep commitment to improving patient care and accelerating scientific research with clinical data is something the entire organization is behind.

Hylton Kalvaria

Senior Vice President,
Commercial and Strategic Partnerships

Hylton Kalvaria is Senior Vice President of Commercial and Strategic Partnerships, leading Verana’s commercial organization, marketing, and major partnership initiatives with medical associations, life science companies, and regulatory bodies. Hylton joins Verana from Flatiron Health, where he founded, built and led the West Coast business, representing half of Flatiron’s commercial activity. In that capacity, Hylton’s team led the design and execution of Flatiron’s first regulatory-grade projects intended for influential stakeholder audiences, including the FDA. Hylton previously held a variety of roles at Genentech and was appointed to lead a CEO-sponsored initiative focused on identifying emerging sources of real-world data and utilizing those data across the Genentech organization, an initiative that led to Roche’s initial investment in Flatiron.

Hylton holds an MBA and BS in Economics from Duke University.

Hylton Kalvaria on LinkedIn
Hylton Kalvaria

Why Verana?

I'm excited to make a big impact on how we generate evidence for new and existing drugs and devices. We have an opportunity to reinvent that process to be more patient and provider focused.

Marie-Eve Piche

Chief Financial Officer

Marie-Eve Piche, Verana’s Chief Financial Officer, has nearly two decades of financial management experience in public and fast-growing private companies. Marie-Eve was previously the CFO of Pymetrics and built the financial strategy and capabilities that enabled a successful Series B fundraising. She also served as Vice President of Financial Planning and Analysis at AppNexus, where she helped grow revenue by more than six times during her tenure and was on the team that drove the $1.6B acquisition by AT&T. She began her career at General Electric, holding key financial roles at NBC Sports and Telemundo.

Marie-Eve received her dual MBA from Columbia University and London Business School. She also holds a Master’s in economics from McGill University and a B.Com. from H.E.C. Montreal.

Marie-Eve Piche on LinkedIn
Marie-Eve Piche

Why Verana?

Verana Health is a company that is doing ground-breaking work with technology and data, and is being built by a team that works tirelessly to deliver against its commitment to patients. I'm thrilled to contribute to the impact I know this company will make.

Matthew Roe, MD, MHS

Chief Medical Officer

Matthew Roe, MD, MHS is Chief Medical Officer at Verana Health, where he leads the cross therapeutic medical team working to ensure the clinical validity and scientific integrity of the company’s research. Additionally, Dr. Roe leads Verana’s regulatory strategy, which focuses on determining how data curated by Verana can be utilized for regulatory decision-making.  A cardiologist and clinical researcher, Dr. Roe joined Verana after spending two decades at the Duke University School of Medicine and the Duke Clinical Research Institute (DCRI), the world’s largest academic research organization. At Duke, he focused on research initiatives leveraging real-world data for observational and prospective studies. Dr. Roe was previously a co-principal investigator for the landmark ADAPTABLE trial and also held leadership positions with several diverse registries focusing upon the treatment and outcomes of patients with cardiovascular disease. At the DCRI, Dr. Roe was Senior Investigator as well as the Director of the organization’s Clinical Research Fellowship and Think Tank series. 

Dr. Roe received his MD and MHS degrees from Duke University School of Medicine in 1993 and 2001, respectively. He completed an Internal Medicine residency at Duke University Medical Center in 1996 and a Cardiovascular Fellowship at the Cleveland Clinic Foundation in 1999.

Matthew Roe, MD, MHS on LinkedIn
Matthew Roe, <span>MD, MHS</span>

Why Verana?

I joined Verana Health to contribute to our mission of leveraging real-world data to enable clinicians to provide the highest quality medical care, to improve the health and quality of life of patients across diverse medical conditions, and to catalyze a transformation of clinical research approaches and processes.

Ann Watson

Senior Vice President,
People & Culture

Ann Watson is Verana’s Senior Vice President of People and Culture, bringing a passion for building teams to Verana’s next phase of growth. The People & Culture team is responsible for all phases of the employee lifecycle: from finding great people to supporting their development all the way through to the alumni phase. Ann has over twenty years of experience in Human Resources and Talent Acquisition, primarily with small and mid-sized technology organizations. Ann was previously the Chief People Officer at MasterClass, at Varo Bank, and ran the Employee Experiences organization at Fandom. She specializes in growing teams from 50 to 500+, doubling the team multiple years in a row, building infrastructure to scale through the early start-up stage to mid-size maturity and beyond.

Ann has a BA from Santa Clara University and is a member of PeopleTechPartners, an organization devoted to accelerating solutions that drive the future of work.

Ann Watson on LinkedIn
Ann Watson

Why Verana?

In addition to being drawn to the incredible mission of improving patient outcomes, the people are why I chose Verana. It is an incredible privilege to work with this team and I’m very appreciative of the overall lack of jerks. Verana is doing great work with great people!

Don Butler

Vice President,
Commercial

Don Butler brings several decades of sales and business leadership experience to Verana Health, where he serves as Vice President, Commercial. Don joins Verana from Outcome Health, where he served as Senior Vice President of Clinical Research Solutions. Prior to Outcome Health, Don was Senior Vice President of Global Enterprise Sales at Medidata Solutions, where he led the global sales team responsible for selling clinical and data analytics solutions that support over half of the world’s clinical trials. He previously held sales leadership roles for Oracle Health Sciences and Siebel Life Sciences.

Don holds a Bachelor’s degree in business from Ithaca College and is an alumnus of Harvard Business School’s extensive executive education program.

Don Butler on LinkedIn
Don Butler

Why Verana?

My career is inspired by the clinical trial that saved my mother’s life from stage 4 ovarian cancer. Verana gives me the opportunity to help connect patients with clinical trials that can improve and save their lives.

Kerry Foster

Vice President,
Deputy General Counsel

Kerry Foster is Vice President, General Counsel and Privacy Officer at Verana Health, where she is responsible for all of the company’s legal functions, including corporate governance, privacy and compliance, commercial contracting, intellectual property activities, and risk management. Kerry has a unique combination of sophisticated legal experience and business acumen honed through over 15 years of experience in healthcare. Prior to joining Verana, Kerry advised national healthcare companies, hospitals, physician groups, and private equity funds on transactional, corporate and healthcare regulatory matters as a Senior Associate at DLA Piper LLP. Kerry has also held various operational positions at large health systems.

Kerry received a JD from the University of Miami School of Law, a MS in Health Systems Management from George Mason University, and a BS in Healthcare Management and Business Administration from Towson University.

Kerry Foster on LinkedIn
Kerry Foster

Why Verana?

I’ve spent my entire career in healthcare and I have always been drawn to organizations that seek to make a difference in people’s lives. Verana’s pursuit of accelerating research for patients through innovative technology is a mission I wanted to be a part of.

Nader Halim, PhD

Vice President, Strategy

Nader Halim is Vice President of Strategy at Verana Health, where he is responsible for the strategic direction of Verana’s clinical trials business and other corporate strategy projects. Nader brings over 20 years of experience in the life sciences industry, including academic research, policy, research and development, and consulting. Most recently, Nader was Senior Director of Emerging Science and Innovation at Pfizer where he led global policy and international public affairs. Prior to Pfizer, Nader led commercial development initiatives at Genentech as Senior Manager of Commercial Assessments, Market Analysis and Strategy. He previously held consulting leadership roles at Quintiles Consulting and Avalere Health, where he consulted in all areas of life science with a focus on pharmaceuticals, devices, and diagnostics. 

Nader received his PhD in Molecular and Cell Biology from the Uniformed Services University of the Health Sciences. He also holds a dual MBA and MPH from Johns Hopkins and a Bachelor’s degree in biology from San Diego State University.

Nader Halim, PhD on LinkedIn
Nader Halim, <span>PhD</span>

Why Verana?

At Verana, we have a real opportunity to leverage big data to better inform clinical decision making, improve the efficiency of research and clinical trials, and impact patient lives.

Chhaya Shadra

Vice President, Product Management, Data & Informatics

Chhaya Shadra is Vice President of Product Management, Data & Informatics, where she is responsible for leading product vision and strategy for data and informatics at Verana Health. Chhaya is an epidemiologist-informatician by training, bringing her deep understanding of systems engineering and user workflow to healthcare technology companies like Converge Health by Deloitte, Humedica by Optum, Syapse, Flatiron Health, and Verana Health. Chhaya’s recent work has focused on product, information architecture and ontology development for integrated precision research data platforms that are sourced from EHR, claims, pharmacy, and medical device data. These platforms are currently being used for real-world observational research, health economics and outcomes research (HEOR), and comparative effectiveness research (CER). Chhaya has focused her informatics career on interoperability and data integrity of routinely captured data that may be used secondarily. 

Chhaya holds a Master’s in Health Informatics from Northeastern University and a Master’s in Health Sciences in Epidemiology from Pune University.

Chhaya Shadra on LinkedIn
Chhaya Shadra

Why Verana?

I’m passionate about innovation and outside the box thinking in healthcare. We have been following the same paradigms of research and evidence generation in healthcare for over half a century, even with the backdrop of technological innovation and vast amounts of data being captured for routine care. Verana’s mission of curating the largest sets of routinely captured specialty data in medicine to accelerate clinical research for the patient is exactly aligned with my personal passion and mission.

Aracelis Torres, PhD, MPH

Senior Director, Data Science

Aracelis Torres, PhD, MPH is Senior Director of Data Science, where she oversees the clinical data science team working to develop and implement rigorous methodology to generate sound scientific evidence from real-world data. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis. 

Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.

Aracelis Torres, PhD, MPH on LinkedIn
Aracelis Torres, <span>PhD, MPH</span>

Why Verana?

Verana’s mission to rigorously generate insights from real-world data is both inspiring and exciting. It provides a unique opportunity to tackle some of the toughest challenges in clinical research while keeping patients at the forefront of our work.

Sonja Wustrack

Vice President,
Commercial

Sonja Wustrack is Vice President, Commercial at Verana Health, where she brings over 20 years of health research experience, including academic research, public health surveillance, clinical trial technology, and clinical research. Within the biotechnology and pharmaceutical space, she has held positions in delivery, operations management, sales enablement leadership and account management. Most recently at IQVIA, Sonja focused on enhancing customer engagement and demonstrating improved value through for pharma, payors, providers and patients by leveraging real-world data and analytics to innovate clinical trial design and accelerate execution.

Sonja holds an MPH in Epidemiology from the Tulane School of Public Health, and a Bachelor’s degree in biology from Vassar College.

Sonja Wustrack on LinkedIn
Sonja Wustrack

Why Verana?

I am inspired by the mission to get the right medicines to patients, faster. At Verana, we have an unparalleled depth of real-world data, combined with the expert data insights and clinical expertise and supported by technology and advanced analytics, to be a partner in shifting the drug development paradigm by enabling acceleration through innovation.

Marc Berger on LinkedIn Marc Berger Interim Chief Executive Officer
Hylton Kalvaria on LinkedIn Hylton Kalvaria Senior Vice President,
Commercial and Strategic Partnerships
Marie-Eve Piche on LinkedIn Marie-Eve Piche Chief Financial Officer
Matthew Roe, MD, MHS on LinkedIn Matthew Roe, MD, MHS Chief Medical Officer
Ann Watson on LinkedIn Ann Watson Senior Vice President,
People & Culture
Don Butler on LinkedIn Don Butler Vice President,
Commercial
Kerry Foster on LinkedIn Kerry Foster Vice President,
Deputy General Counsel
Nader Halim, PhD on LinkedIn Nader Halim, PhD Vice President, Strategy
Chhaya Shadra on LinkedIn Chhaya Shadra Vice President, Product Management, Data & Informatics
Aracelis Torres, PhD, MPH on LinkedIn Aracelis Torres, PhD, MPH Senior Director, Data Science
Sonja Wustrack on LinkedIn Sonja Wustrack Vice President,
Commercial

Our Board

Brook Byers (Chairman)

Founding Partner,
Kleiner, Perkins, Caufield & Byers

Mark Blumenkranz, MD

Co-founder,
Verana Health and Lagunita Biosciences

David W. Parke II, MD

Chief Executive Officer,
American Academy of Ophthalmology

Steven Schwartz, MD

Ahmanson Professor in Ophthalmology,
Stein Eye Institute, UCLA

Michael T. Sheppard, CPA, CAE

Chief Executive Officer,
American Urological Association

James C. Stevens, MD, FAAN

President,
American Academy of Neurology

Julie Sunderland

Co-Founder and Managing Director,
Biomatics Capital Partners

Krishna Yeshwant, MD

Managing Partner,
GV

Brendan Bulik-Sullivan (Observer)

Partner,
GV

Eli Casdin (Observer)

Chief Investment Officer and Founder,
Casdin Capital

Our Advisors

Miki Kapoor

Co-Founder and Senior Advisor

Theodore Leng, MD

Medical Advisor

Jennifer Cook

Strategic Advisor

Our Investors

Verana Health is backed by leading institutional investors and industry veterans:

Google Ventures
Bain Capital Ventures
Casdin Capital
Define Ventures
Biomatics Capital
Lagunita Biosciences
Revelation Partners

Brook Byers, founding member and senior partner of Kleiner, Perkins, Caufield, and Byers.